← Back to the disclosure log

Who in Congress Has Traded Boston Scientific Corporation (BSX)?

The Boston Scientific Corporation line shows up 49 times in the congressional disclosure record between 2015 and 2026, filed by 14 members: 22 purchases against 27 sales. On balance the chamber has been net sellers, and the purchases sit down 29.4% against the latest close.

49Trades
22Buys
27Sells
14Members
$46.84Latest close 2026-08-28
-29.4%Congress buys vs latest close*

*Purchases only, weighted by the midpoint of each disclosed dollar band and marked to the latest close. Filings report a range, never a share count, so this follows the stock rather than anyone's position size.

45% buys55% sells

Recent buyers of BSX

Reported a BSX purchase in filings from the last 90 days, newest first. 1 member.

How it splits by party

Democrats
14 buys · 19 sells
6 members · 33 trades
Republicans
5 buys · 6 sells
6 members · 11 trades

Whose BSX buys have done best

Members ranked by how their reported BSX purchases have moved since, over roughly the last three years, weighted by disclosed band midpoint and marked to the latest close.

1 Gilbert Cisneros
-3.5%
2 Markwayne Mullin
-29.1%
3 Alan Armstrong
-32.3%
4 John Boozman
-55.9%
DateMemberTypeAmountEst. priceLatest closeReturn
2026-06-05Gilbert CisnerosSELL$1K–$15K$48.55$46.84 2026-08-280.0% rt
2026-06-05Gilbert CisnerosBUY$1K–$15K$48.55$46.84 2026-08-28-3.5%
2026-06-04John BoozmanSELL$1K–$15K$48.85$46.84 2026-08-28+4.1% exit
2026-03-27Alan ArmstrongBUY$1K–$15K$69.17$46.84 2026-08-28-32.3%
2025-12-29Markwayne MullinBUY$15K–$50K$95.76$46.84 2026-08-28-51.1%
2025-12-17John BoozmanSELL$1K–$15K$94.48$46.84 2026-08-28-11.0% rt
2025-10-28Kevin HernSELL$15K–$50K$100.97$46.84 2026-08-28+53.6% exit
2025-07-31Gilbert CisnerosSELL$1K–$15K$104.92$46.84 2026-08-28+55.4% exit
2025-02-24Gilbert CisnerosSELL$1K–$15K$104.39$46.84 2026-08-28+55.1% exit
2025-02-13John BoozmanBUY$1K–$15K$106.14$46.84 2026-08-28-55.9%
2023-10-03Markwayne MullinBUY$1K–$15K$51.54$46.84 2026-08-28-9.1%
2023-09-13Markwayne MullinBUY$15K–$50K$53.20$46.84 2026-08-28-11.9%
2023-05-31Lois FrankelSELL$1K–$15K$51.48$46.84 2026-08-28+31.6% rt
2023-05-30Lois FrankelBUY$1K–$15K$50.49$46.84 2026-08-28-7.2%
2023-05-01Lois FrankelSELL$1K–$15K$52.80$46.84 2026-08-28+42.1% rt
2023-04-26John CurtisSELL$1K–$15K$51.10$46.84 2026-08-28+8.3% exit
2023-04-19Lois FrankelSELL$1K–$15K$52.89$46.84 2026-08-28+68.3% rt
2023-03-29Lois FrankelSELL$1K–$15K$49.08$46.84 2026-08-28+80.2% rt
2023-02-23John CurtisSELL$1K–$15K$47.18$46.84 2026-08-28+0.7% exit
2022-10-24Alan S. LowenthalSELL$1K–$15K$40.98$46.84 2026-08-28+11.8% rt
2022-10-21Alan S. LowenthalSELL$1K–$15K$40.57$46.84 2026-08-28+12.8% rt
2022-10-21Alan S. LowenthalSELL$1K–$15K$40.57$46.84 2026-08-28+10.7% rt
2022-09-28Lois FrankelBUY$1K–$15K$39.13$46.84 2026-08-28+19.7%
2021-12-16Robert J. WittmanSELL$1K–$15K$40.43$46.84 2026-08-28+5.1% rt
2021-08-06Alan S. LowenthalSELL$1K–$15K$44.70$46.84 2026-08-28+24.3% rt
2021-08-03Alan S. LowenthalSELL$1K–$15K$45.54$46.84 2026-08-28+26.7% rt
2021-02-02Alan S. LowenthalBUY$1K–$15K$36.64$46.84 2026-08-28+27.8%
2021-02-02Alan S. LowenthalBUY$624.29–$624.29$36.64$46.84 2026-08-28+27.8%
2021-02-02Alan S. LowenthalBUY$330.51–$330.51$36.64$46.84 2026-08-28+27.8%
2021-02-01Alan S. LowenthalBUY$15K–$50K$35.95$46.84 2026-08-28+30.3%
2021-02-01Alan S. LowenthalBUY$1K–$15K$35.95$46.84 2026-08-28+30.3%
2021-02-01Alan S. LowenthalBUY$860.95–$860.95$35.95$46.84 2026-08-28+30.3%
2020-10-21Lois FrankelBUY$1K–$15K$37.15$46.84 2026-08-28+26.1%
2020-10-02Robert J. WittmanBUY$1K–$15K$38.48$46.84 2026-08-28+21.7%
2020-08-10Dean PhillipsBUY$1K–$15K$38.98$46.84 2026-08-28+20.2%
2020-03-26Lois FrankelBUY$1K–$15K$31.42$46.84 2026-08-28+49.1%
2020-03-19Alan S. LowenthalSELL$460.82–$460.82$28.27$46.84 2026-08-28-65.7% exit
2020-03-19Alan S. LowenthalSELL$1K–$15K$28.27$46.84 2026-08-28-65.7% exit
2020-03-18Lois FrankelBUY$1K–$15K$27.24$46.84 2026-08-28+72.0%
2020-03-13Alan S. LowenthalSELL$614.21–$614.21$32.33$46.84 2026-08-28+16.7% rt
2020-03-11Alan S. LowenthalSELL$1K–$15K$33.86$46.84 2026-08-28+32.2% rt
2020-02-27Josh GottheimerSELL$1K–$15K$37.92$46.84 2026-08-28-23.5% exit
2020-02-05Mo BrooksSELL$1K–$15K$42.62$46.84 2026-08-28-9.9% exit
2019-07-30Lois FrankelSELL$1K–$15K$42.86$46.84 2026-08-28-9.3% exit
2019-04-25Susie LeeSELL$1K–$15K$36.93$46.84 2026-08-28-26.8% exit
2018-01-22Alan S. LowenthalBUY$962.57–$962.57$27.71$46.84 2026-08-28+69.0%
2017-12-14Alan S. LowenthalBUY$15K–$50K$25.62$46.84 2026-08-28+82.8%
2017-02-01Lois FrankelSELL$1K–$15K$23.96$46.84 2026-08-28-95.5% exit
2015-03-18K. Michael ConawayBUY$1K–$15K$17.76$46.84 2026-08-28+163.7%

Buys are marked to the latest close and treated as open. A sell tagged rt closes an earlier disclosed buy in the same name. exit shows how the stock moved after the member sold.

Frequently asked — Boston Scientific Corporation (BSX) congressional trades

Which lawmakers have traded Boston Scientific Corporation (BSX)?

14 members of the U.S. House and Senate have disclosed Boston Scientific Corporation transactions under the STOCK Act — 22 purchases and 27 sales. The full member-by-member breakdown, with dates and dollar ranges, is in the table above.

Which lawmakers bought BSX recently?

1 member disclosed a BSX purchase in the last 90 days — most recently Gilbert Cisneros on 2026-06-05. See the "Lawmakers who bought BSX recently" section above for the dated list.

How have Congress's BSX trades performed?

Notional-weighted, lawmakers' disclosed BSX buys are down 29.4% versus the latest close of $46.84. Each trade's own return — and realized round-trips on matched sells — is in the Return column.

Is it legal for members of Congress to trade Boston Scientific Corporation?

Yes. Under the 2012 STOCK Act, members of Congress may buy and sell individual stocks but must publicly disclose each transaction within 45 days. Bargo surfaces those filings so you can see who traded BSX and how it performed.

Related stocks — also traded by the same lawmakers

JPM 12AAPL 11UNH 11AMZN 11MSFT 10GS 10UNP 10CMCSA 10COST 10ACN 9JNJ 9PFE 9ABT 9V 9PG 9HD 8XOM 8ADBE 8